tetano
Editor, Senior Moderator
Korean J Pediatr. 2012 Dec;55(12):474-80. doi: 10.3345/kjp.2012.55.12.474. Epub 2012 Dec 20.
Evaluation of immunogenicity of the 2008-2009 seasonal influenza vaccines by microneutralization test.
Kim SY, Kim YK, Eun BW, Kim NH, Kang EK, Lee BS, Lim JS, Lee JA, Kim DH.
Source
Department of Pediatrics, Korean Cancer Center Hospital, Seoul, Korea.
Abstract
PURPOSE:
For evaluating the immunogenicity of an influenza vaccine, the microneutralization (MN) test has a higher sensitivity and specificity as compared to the hemagglutination inhibition (HI) test. However, the MN test is more time consuming and is difficult to standardize. We performed the MN test to determine its usefulness as an alternative or complementary test to the HI test for evaluating the immunogenicity of influenza vaccines.
METHODS:
We compared the MN test with the HI test using 50 paired samples taken from a previous clinical study (2008-2009) in Korean children under 18 years of age.
RESULTS:
The linear correlation coefficients of the 2 tests for H3N2, H1N1, and influenza B were 0.69, 0.70, and 0.66, respectively. We identified a high index of coincidence between the 2 tests. For an influenza vaccine, the postvaccination seroprotection rates and seroconversion rates determined by the MN test were 78.0% and 96.0%, 90% and 42.0%, and 42.0% and 48.0% for H3N2, H1N1, and influenza B, respectively. Geometric mean titer fold increases of H3N2, H1N1, and influenza B were 2.89, 5.04, and 4.29, respectively, and were 2.5-fold higher. We obtained good results in the evaluation of the immunogenicity of the 2008-2009 seasonal influenza vaccines.
CONCLUSION:
We found that the MN test was as effective as the HI test. Therefore, we suggest that the MN test can be used as an alternative or complementary test to the HI test for evaluating the immunogenicity of influenza vaccines.
PMID:
23300503
[PubMed]
PMCID:
PMC3534161
Free full text
http://www.ncbi.nlm.nih.gov/pubmed/23300503
Evaluation of immunogenicity of the 2008-2009 seasonal influenza vaccines by microneutralization test.
Kim SY, Kim YK, Eun BW, Kim NH, Kang EK, Lee BS, Lim JS, Lee JA, Kim DH.
Source
Department of Pediatrics, Korean Cancer Center Hospital, Seoul, Korea.
Abstract
PURPOSE:
For evaluating the immunogenicity of an influenza vaccine, the microneutralization (MN) test has a higher sensitivity and specificity as compared to the hemagglutination inhibition (HI) test. However, the MN test is more time consuming and is difficult to standardize. We performed the MN test to determine its usefulness as an alternative or complementary test to the HI test for evaluating the immunogenicity of influenza vaccines.
METHODS:
We compared the MN test with the HI test using 50 paired samples taken from a previous clinical study (2008-2009) in Korean children under 18 years of age.
RESULTS:
The linear correlation coefficients of the 2 tests for H3N2, H1N1, and influenza B were 0.69, 0.70, and 0.66, respectively. We identified a high index of coincidence between the 2 tests. For an influenza vaccine, the postvaccination seroprotection rates and seroconversion rates determined by the MN test were 78.0% and 96.0%, 90% and 42.0%, and 42.0% and 48.0% for H3N2, H1N1, and influenza B, respectively. Geometric mean titer fold increases of H3N2, H1N1, and influenza B were 2.89, 5.04, and 4.29, respectively, and were 2.5-fold higher. We obtained good results in the evaluation of the immunogenicity of the 2008-2009 seasonal influenza vaccines.
CONCLUSION:
We found that the MN test was as effective as the HI test. Therefore, we suggest that the MN test can be used as an alternative or complementary test to the HI test for evaluating the immunogenicity of influenza vaccines.
PMID:
23300503
[PubMed]
PMCID:
PMC3534161
Free full text
http://www.ncbi.nlm.nih.gov/pubmed/23300503